The five-year survival rate for mesothelioma patients is approximately 12%. About 40% of mesothelioma patients survive at least one year after diagnosis. The one-year survival rate is approximately 73% for pleural mesothelioma and 92% for peritoneal mesothelioma.
Survival rate typically refers to the percentage of people with cancer who live one and five years after initial diagnosis. These measures are referred to as the one-year and five-year mesothelioma survival rates.
What Are Mesothelioma Survival Rates?
Survival rate typically refers to the percentage of people with cancer who live one and five years after initial diagnosis. These measures are referred to as the one-year and five-year mesothelioma survival rates.
When discussing survival rates, you may hear other related terms such as life expectancy, which is the average time a person is expected to live based on birth year, current age, gender and other factors.
Mesothelioma affects life expectancy because the cancer reduces the number of years a patient is expected to live.
A 2015 meta-study published in Translational Oncology analyzed 20 years of data, collected from 1992 to 2012. The five-year survival rate for peritoneal mesothelioma patients was more than five-times higher than the rate for pleural patients.Pleural and Peritoneal Mesothelioma Survival Rates
| YEAR(S) | PLEURAL | PERITONEAL |
|---|---|---|
| 1 year | 73% | 92% |
| 3 years | 23% | 74% |
| 5 years | 12% | 52% |
| 10 years | 4.7% | 39% |
Factors Affecting Mesothelioma Survival Rate
There are several things that affect how long a person will live after a mesothelioma diagnosis.
INDIVIDUAL CHARACTERISTICS AND MESOTHELIOMA SURVIVAL
- Tumor Location
- Stage of disease
- Mesothelioma cell type
- Age at diagnosis and overall health
- Gender
- Race/Ethnicity
A 2018 analysis of 888 cases in the National Mesothelioma Virtual Bank cohort identified median overall survival of 15 months, on average, for pleural and peritoneal patients combined.
The most important factors associated with better survival were age (less then 45), female gender, epithelioid cell type, stage 1 disease, peritoneal occurrence and treatment combining surgery with chemotherapy.